17 min
A Breakthrough in Wearable Neuromodulation Medical Design Briefs Podcast
-
- Life Sciences
Surgery- and drug-free at-home wearable neuromodulation
represents a huge advancement for a variety of clinical conditions, including overactive bladder syndrome, which affects more than 46 million people in the U.S. On this episode of Medical Design Briefs’ Podcast, Jill Schiaparelli, CEO of Avation Medical discusses the first FDA-cleared, non-invasive, closed-loop wearable neuromodulation technology for at-home bladder treatment. From understanding the technology behind it to its real-world impact on patients and clinicians, this podcast uncovers the potential of wearable neuromodulation in revolutionizing the treatment of OAB.
Surgery- and drug-free at-home wearable neuromodulation
represents a huge advancement for a variety of clinical conditions, including overactive bladder syndrome, which affects more than 46 million people in the U.S. On this episode of Medical Design Briefs’ Podcast, Jill Schiaparelli, CEO of Avation Medical discusses the first FDA-cleared, non-invasive, closed-loop wearable neuromodulation technology for at-home bladder treatment. From understanding the technology behind it to its real-world impact on patients and clinicians, this podcast uncovers the potential of wearable neuromodulation in revolutionizing the treatment of OAB.
17 min